AQUASOL A

Manufacturer
Hospira, Inc.
Effective date
2021-08-02
Label type
Human Prescription Drug Label
Version
21
Source
legacy-cache
Hydrated at
2026-08-01 22:39:11

Label at a glance#

ProductAQUASOL A
Active ingredientVITAMIN A PALMITATE
Label structure16 sections

Dosage and administration

For intramuscular use. I. Adults 100,000 Units daily for three days followed by 50,000 Units daily for two weeks. II. Pediatric patients 1 to 8 years old 17,500 to 35,000 Units daily for 10 days. III. Infants 7,500 to 15,000 Units daily for 10 days. Follow-up therapy with an oral therapeutic multivitamin preparation, containing 10,000 to 20,000 Units vitamin A for adults and for pediatric patients over 8 years old...

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

water-miscible vitamin A Palmitate
50,000 USP Units (15 mg retinol/mL)

THIS IS A STERILE PRODUCT FOR INTRAMUSCULAR INJECTION

DESCRIPTION

DESCRIPTION SECTION

AQUASOL ATMParenteral (water-miscible vitamin A Palmitate) provides 50,000 USP Units of vitamin A per mL as retinol (C20H30O) in the form of vitamin A palmitate, a light yellow to amber oil. Contains 0.5% chlorobutanol as preservative; 12% polysorbate 80, 0.1% citric acid, and sodium hydroxide to adjust pH. The structural formula of retinol is:

aquasol-01aquasol-01

Ordinarily oil-soluble, the vitamin A in this product has been water solubilized by special processing* and is available in a water solution for intramuscular injection.

One USP Unit is equivalent to one international unit (IU) and to 0.3 mcg of retinol or 0.6 mcg of betacarotene.

CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY SECTION

Beta-carotene, retinol, and retinal have effective and reliable vitamin A activity. Retinal and retinol are in chemical equilibrium in the body and have equivalent antixerophthalmic activity. Retinal combines with the rod pigment, opsin, in the retina to form rhodopsin, necessary for visual dark adaptation. Vitamin A prevents retardation of growth and preserves the epithelial cells' integrity. Normal adult liver storage is sufficient to satisfy two years' requirements of vitamin A.

Vitamin A is readily absorbed from the gastrointestinal tract, where the biosynthesis of vitamin A from beta-carotene takes place. Vitamin A absorption requires bile salts, pancreatic lipase, and dietary fat. It is transported in the blood to the liver by the chylomicron fraction of the lymph. Vitamin A is stored in Kupffer cells of the liver mainly as the palmitate. Normal serum vitamin A is 80–300 Units per 100 mL (plasma range is 30–70 mcg per dl) and for carotenoids 270–753 Units per 100 mL. The normal adult liver contains approximately 100 to 300 micrograms per gram, mostly as retinol palmitate.

*Oil-soluble vitamin A water solubilized with polysorbate 80.

INDICATIONS

INDICATIONS & USAGE SECTION

Vitamin A injection is effective for the treatment of vitamin A deficiency.

The parenteral administration is indicated when the oral administration is not feasible as in anorexia, nausea, vomiting, pre- and postoperative conditions, or it is not available as in the "Malabsorption Syndrome" with accompanying steatorrhea.

Pediatric Use: Vitamin A treatment for deficiency states has been recognized as an especially effective and important therapy in the pediatric population.

Vitamin A supplementation for deficiency states in this population has been addressed by the Committee on Clinical Practice Issues of the American Society for Clinical Nutrition, by the American Society for Parenteral and Enteral Nutrition, and by the World Health Organization.

CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

The intravenous administration. Hypervitaminosis A. Sensitivity to any of the ingredients in this preparation.

Use in Pregnancy: Safety of amounts exceeding 6,000 Units of vitamin A daily during pregnancy has not been established at this time. The use of vitamin A in excess of the recommended dietary allowance may cause fetal harm when administered to a pregnant woman. Animal reproduction studies have shown fetal abnormalities associated with overdosage in several species. Malformations of the central nervous system, the eye, the palate, and the urogenital tract are recorded. Vitamin A in excess of the recommended dietary allowance is contraindicated in women who are or may become pregnant. If vitamin A is used during pregnancy, or if the patient becomes pregnant while taking vitamin A, the patient should be apprised of the potential hazard to the fetus.

WARNINGS

WARNINGS SECTION

Avoid overdosage. Keep out of the reach of children.

Pediatric Use: Polysorbates have been associated with E-Ferol syndrome (thrombocytopenia, renal dysfunction, hepatomegaly, cholestasis, ascites, hypotension and metabolic acidosis) in low birthweight infants.

PRECAUTIONS

PRECAUTIONS SECTION

General: Protect from light. Prolonged daily dose administration over 25,000 Units vitamin A should be under close supervision. Blood level assays are not a direct measure of liver storage. Liver storage should be adequate before discontinuing therapy. Single vitamin A deficiency is rare. Multiple vitamin deficiency is expected in any dietary deficiency.

Drug Interactions: Women on oral contraceptives have shown a significant increase in plasma vitamin A levels.

Carcinogenesis: There are no studies that show that administration of vitamin A will cause or prevent cancer.

Pregnancy:

See CONTRAINDICATIONS section.

Nursing Mothers: The U.S. Recommended Daily Allowance (RDA) of vitamin A (5,000 Units) is recommended for nursing mothers.

ADVERSE REACTIONS

ADVERSE REACTIONS SECTION

See OVERDOSAGE section. Anaphylactic shock and death have been reported using the intravenous route. Allergic reactions have been reported rarely with administration of AQUASOL ATM Parenteral including one case of an anaphylactoid type reaction.

OVERDOSAGE

OVERDOSAGE SECTION

The following amounts have been found to be toxic orally. Toxicity manifestations depend on the age, dosage, size, and duration of administration.

Acute toxicity — single dose (25,000 Units/kg body weight)
   Infant: 350,000 Units
   Adult: Over 2 million Units

Chronic toxicity (4,000 Units/kg body weight for 6 to 15 months)
   Infants 3 to 6 months old: 18,500 Units (water dispersed)/day for 1 to 3 months.
   Adult: 1 million Units daily for three days; 50,000 Units daily for longer than 18 months; 500,000 Units daily for two months.

Hypervitaminosis A Syndrome:

  • General manifestations:
    Fatigue, malaise, lethargy, abdominal discomfort, anorexia, and vomiting.
  • Specific manifestations:
  • a. Skeletal: hepatotoxicity, hard tender cortical thickening over the radius and tibia, migratory arthralgia, slow growth, and premature closure of the epiphysis leading to arrested bone growth in children.
    b. Central Nervous System: irritability, headache, and increased intracranial pressure as manifested by bulging fontanels, papilledema, and exophthalmos.
    c. Dermatologic: fissures of the lips, drying and cracking of the skin, alopecia, scaling, massive desquamation, and increased pigmentation.
    d. Systemic: hypomenorrhea, hepatosplenomegaly, hepatotoxicity, jaundice, leukopenia, vitamin A plasma level over 1,200 Units/100 mL.

The treatment of hypervitaminosis A consists of immediate withdrawal of the vitamin along with symptomatic and supportive treatment.

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

For intramuscular use.

  • Adults
    100,000 Units daily for three days followed by 50,000 Units daily for two weeks.
  • Pediatric patients 1 to 8 years old
    17,500 to 35,000 Units daily for 10 days.
  • Infants
    7,500 to 15,000 Units daily for 10 days.

Follow-up therapy with an oral therapeutic multivitamin preparation, containing 10,000 to 20,000 Units vitamin A for adults and for pediatric patients over 8 years old, and 5,000 to 10,000 Units for infants and other pediatric patients under 8 years old, is recommended daily for two months. Low birth-weight infants may require additional vitamin A though the exact dosing in these pediatric patients has not been established. In malabsorption, the parenteral route must be used for an equivalent preparation.

Poor dietary habits should be corrected and an abundant and well-balanced dietary intake should be prescribed.

HOW SUPPLIED

HOW SUPPLIED SECTION

AQUASOL ATMParenteral (water-miscible vitamin A Palmitate) is available as:

Unit of SaleConcentrationEach
NDC 61703-418-07Carton of 1050,000 USP units/mL
(15 mg retinol/mL)
NDC 61703-418-09
2 mL Single-dose vial
NDC 61703-418-18Carton of 150,000 USP units/mL
(15 mg retinol/mL)
NDC 61703-418-18
2 mL Single-dose vial

Store at 2–8°C (36–46°F). Do not freeze.

Hospira, In

Revised: 01/2018c., Lake Forest, IL 60045 USA                                                                                                                        aquasol-02aquasol-02

LAB-1245-1.0

PRINCIPAL DISPLAY PANEL - 2 mL Vial Label - RL-4489

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

2 mL Single-dose
Rx only
NDC 61703-418-09

AQUASOL A™
Parenteral
Water-Miscible Vitamin A Palmitate

50,000 USP units/mL (15 mg retinol)
For Intramuscular Use.
Sterile

Hospira, Inc.
Lake Forest, IL 60045 USA

RL-4489

aquasol-03aquasol-03

PRINCIPAL DISPLAY PANEL - 2 mL Vial Carton - CA-6122

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

10 x 2 mL Single-dose Vials
Sterile
NDC 61703-418-07

Rx only

AQUASOL A™
Parenteral
Water-Miscible Vitamin A Palmitate

50,000 USP units/mL (15 mg retinol)
For Intramuscular Use.

Hospira

aquasol-04aquasol-04

PRINCIPAL DISPLAY PANEL - 2 mL Vial Label - RL-4645

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

2 mL Single-dose
Rx only
NDC 61703-418-18

AQUASOL A™
Parenteral
Water-Miscible Vitamin A Palmitate

50,000 USP units/mL (15 mg retinol)
For Intramuscular Use.
Sterile

Hospira, Inc.
Lake Forest, IL 60045 USA

RL-4645

aquasol-05aquasol-05

PRINCIPAL DISPLAY PANEL - 2 mL Vial Carton - CA-4646

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

2 mL
Single-dose Vials
Sterile

NDC 61703-418-18
Rx only

AQUASOL A™
Parenteral
Water-Miscible
Vitamin A Palmitate

50,000 USP units/mL
(15 mg retinol)
For Intramuscular Use.

Hospira, Inc.
Lake Forest, IL 60045 USA

Hospira

aquasol-06aquasol-06

PRINCIPAL DISPLAY PANEL - 2 mL Vial Tray

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

25 x 2 mL Single-dose Vials
Sterile
NDC 61703-418-18

Rx only

AQUASOL A™
Parenteral
Water-Miscible Vitamin A Palmitate

50,000 USP units/mL (15 mg retinol)
For Intramuscular Use.

Hospira

aquasol-07aquasol-07

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
61703-418-07ML - Milliliter61703-41815a9cf6a-62e6-4afe-b6ef-94e18106a71b12012-07-24
61703-418-18ML - Milliliter61703-418ed3e404a-3698-4bd2-b691-ef7f8c8a830412015-02-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
VITAMIN A PALMITATEACTIVE INGREDIENT1D1K0N0VVC13
RETINOLACTIVE MOIETYG2SH0XKK9113
CHLOROBUTANOLINACTIVE INGREDIENTHM4YQM8WRC13
CITRIC ACID MONOHYDRATEINACTIVE INGREDIENT2968PHW8QP13
POLYSORBATE 80INACTIVE INGREDIENT6OZP39ZG8H13
SODIUM HYDROXIDEINACTIVE INGREDIENT55X04QC32I13

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
61703-41861703-418-09, 61703-418-07, 61703-418-18

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 6 · 356 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
CHLOROBUTANOLCHLOROBUTANOLHM4YQM8WRCSPRAY, METERED / NASAL20 mgExact identifier — unii candidate
16 equally ranked IID candidates
CHLOROBUTANOLCHLOROBUTANOLHM4YQM8WRCINJECTION / PARENTERAL0.5 %w/vExact identifier — unii candidate
16 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IGEL / TOPICAL70 mgExact identifier — unii candidate
174 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPSOLUTION / INTRAVENOUS10 mgExact identifier — unii candidate
88 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, POWDER, FOR SOLUTION / INTRADISCALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IDISC / TOPICALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPSHAMPOO / TOPICAL18 mgExact identifier — unii candidate
88 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IPOWDER, FOR SUSPENSION / ORAL9 mgExact identifier — unii candidate
174 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HSUSPENSION / OPHTHALMIC1 mgExact identifier — unii candidate
78 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR5.4 mgExact identifier — unii candidate
174 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPINJECTION, POWDER, FOR SOLUTION / INTRAMUSCULARNAExact identifier — unii candidate
88 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HAEROSOL, FOAM / TOPICAL0.98 %w/wExact identifier — unii candidate
78 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPSUSPENSION, EXTENDED RELEASE / ORAL140.8 mgExact identifier — unii candidate
88 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPFILM / SUBLINGUAL10 mgExact identifier — unii candidate
88 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HSOLUTION / OPHTHALMIC8 mgExact identifier — unii candidate
78 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ITABLET, COATED / ORALNAExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IEMULSION / ORALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HINJECTION / INTRALESIONAL4 mgExact identifier — unii candidate
78 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ITABLET / ORAL10 mgExact identifier — unii candidate
174 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPSHAMPOO, SUSPENSION / TOPICAL0.25 %w/vExact identifier — unii candidate
88 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPTABLET, EXTENDED RELEASE / ORAL45 mgExact identifier — unii candidate
88 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUSADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPCONCENTRATE / ORAL5.3 mg/1mlExact identifier — unii candidate
88 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HLIQUID / INTRAVENOUS720 mgExact identifier — unii candidate
78 equally ranked IID candidates
CHLOROBUTANOLCHLOROBUTANOLHM4YQM8WRCSUSPENSION / INTRAMUSCULAR3.5 mgExact identifier — unii candidate
16 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISUSPENSION, EXTENDED RELEASE / SUBCUTANEOUSNAExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION / INTRA-ARTICULARADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPINJECTION / EPIDURAL0.02 %w/vExact identifier — unii candidate
88 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HINJECTION, SUSPENSION / INTRAMUSCULAR4 mgExact identifier — unii candidate
78 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HSOLUTION, GEL FORMING, EXTENDED RELEASE / OPHTHALMIC0.05 %w/wExact identifier — unii candidate
78 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISOLUTION / EPIDURALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HINJECTION / INTRA-ARTICULAR4 mgExact identifier — unii candidate
78 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, SOLUTION / INTRATHECALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HINJECTION / INTRAMUSCULAR4 %w/vExact identifier — unii candidate
78 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, SUSPENSION / SUBCUTANEOUSADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HEMULSION / TOPICAL34050 mgExact identifier — unii candidate
78 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPINJECTION, SOLUTION, CONCENTRATE / IRRIGATION1 mgExact identifier — unii candidate
88 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IPASTE / DENTAL0.6 %w/wExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION / INTRA-AMNIOTICADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HCAPSULE, COATED PELLETS / ORAL2 mgExact identifier — unii candidate
78 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISOLUTION / INTRAOCULARADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
CHLOROBUTANOLCHLOROBUTANOLHM4YQM8WRCINHALANT / RESPIRATORY (INHALATION)3 mgExact identifier — unii candidate
16 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HSOLUTION/ DROPS / AURICULAR (OTIC)13 mgExact identifier — unii candidate
78 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISOLUTION / URETERALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HOINTMENT / TOPICAL0.1 %w/wExact identifier — unii candidate
78 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPGEL / TOPICAL1 mgExact identifier — unii candidate
88 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, POWDER, FOR SOLUTION / INTRA-ARTERIALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPELIXIR / ORAL100 mg/5mlExact identifier — unii candidate
88 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVITARYADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IAEROSOL, METERED / RESPIRATORY (INHALATION)ADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, SOLUTION / INTRAVESICALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IPOWDER, FOR SUSPENSION / ENDOTRACHEALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPSYSTEM / TOPICAL0.2 mgExact identifier — unii candidate
88 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPINJECTION / INTRAMUSCULAR28 mgExact identifier — unii candidate
88 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ICREAM, AUGMENTED / TOPICAL6 mgExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISOLUTION / OPHTHALMIC0.05 %w/vExact identifier — unii candidate
174 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPINJECTION / INTRALESIONALADJ PHExact identifier — unii candidate
88 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPSOLUTION / IONTOPHORESIS0.02 %w/vExact identifier — unii candidate
88 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IFILM / BUCCAL0.09 mgExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IDROPS / OPHTHALMICNAExact identifier — unii candidate
174 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N006823-001AQUASOL AVITAMIN A PALMITATEEQ 50,000 UNITS BASE/MLINJECTABLE / INJECTIONRLD, RS, Approved before 1982

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 45 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10N006823-001AQUASOL AEQ 50,000 UNITS BASE/MLINJECTABLE / INJECTIONRLD, RS, Approved before 1982d4dbc9d85df4…
2026-10-15 13:18:302026-09N006823-001AQUASOL AEQ 50,000 UNITS BASE/MLINJECTABLE / INJECTIONRLD, RS, Approved before 1982c2088c7a36db…
2026-09-14 22:38:342026-08N006823-001AQUASOL AEQ 50,000 UNITS BASE/MLINJECTABLE / INJECTIONRLD, RS, Approved before 198284e616aacf4f…
2026-08-18 06:07:402026-07N006823-001AQUASOL AEQ 50,000 UNITS BASE/MLINJECTABLE / INJECTIONRLD, RS, Approved before 1982caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N006823-001AQUASOL AEQ 50,000 UNITS BASE/MLINJECTABLE / INJECTIONRLD, RS, Approved before 1982011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N006823-001AQUASOL AEQ 50,000 UNITS BASE/MLINJECTABLE / INJECTIONRLD, RS, Approved before 198231067a03dcf5…
2025-08-23 18:47 UTC2025-08N006823-001AQUASOL AEQ 50,000 UNITS BASE/MLINJECTABLE / INJECTIONRLD, RS, Approved before 19826a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N006823-001AQUASOL AEQ 50,000 UNITS BASE/MLINJECTABLE / INJECTIONRLD, RS, Approved before 1982fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N006823-001AQUASOL AEQ 50,000 UNITS BASE/MLINJECTABLE / INJECTIONRLD, RS, Approved before 1982b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N006823-001AQUASOL AEQ 50,000 UNITS BASE/MLINJECTABLE / INJECTIONRLD, RS, Approved before 198203ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N006823-001AQUASOL AEQ 50,000 UNITS BASE/MLINJECTABLE / INJECTIONRLD, RS, Approved before 19822680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N006823-001AQUASOL AEQ 50,000 UNITS BASE/MLINJECTABLE / INJECTIONRLD, RS, Approved before 19825bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N006823-001AQUASOL AEQ 50,000 UNITS BASE/MLINJECTABLE / INJECTIONRLD, RS, Approved before 1982d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N006823-001AQUASOL AEQ 50,000 UNITS BASE/MLINJECTABLE / INJECTIONRLD, RS, Approved before 1982d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N006823-001AQUASOL AEQ 50,000 UNITS BASE/MLINJECTABLE / INJECTIONRLD, RS, Approved before 198279d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N006823-001AQUASOL AEQ 50,000 UNITS BASE/MLINJECTABLE / INJECTIONRLD, RS, Approved before 1982301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N006823-001AQUASOL AEQ 50,000 UNITS BASE/MLINJECTABLE / INJECTIONRLD, RS, Approved before 19821e350fbaab3a…
2024-05-31 18:47 UTC2024-05N006823-001AQUASOL AEQ 50,000 UNITS BASE/MLINJECTABLE / INJECTIONRLD, RS, Approved before 19828072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N006823-001AQUASOL AEQ 50,000 UNITS BASE/MLINJECTABLE / INJECTIONRLD, RS, Approved before 19825c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N006823-001AQUASOL AEQ 50,000 UNITS BASE/MLINJECTABLE / INJECTIONRLD, RS, Approved before 19825d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N006823-001AQUASOL AEQ 50,000 UNITS BASE/MLINJECTABLE / INJECTIONRLD, RS, Approved before 19824b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N006823-001AQUASOL AEQ 50,000 UNITS BASE/MLINJECTABLE / INJECTIONRLD, RS, Approved before 198274a2ff9319b5…
2022-03-09 01:35 UTC2022-03N006823-001AQUASOL AEQ 50,000 UNITS BASE/MLINJECTABLE / INJECTIONRLD, RS, Approved before 1982bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N006823-001AQUASOL AEQ 50,000 UNITS BASE/MLINJECTABLE / INJECTIONRLD, RS, Approved before 1982782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N006823-001AQUASOL AEQ 50,000 UNITS BASE/MLINJECTABLE / INJECTIONRLD, RS, Approved before 198287673890dc5c…
2021-03-12 10:30 UTC2021-03N006823-001AQUASOL AEQ 50,000 UNITS BASE/MLINJECTABLE / INJECTIONRLD, RS, Approved before 19825aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N006823-001AQUASOL AEQ 50,000 UNITS BASE/MLINJECTABLE / INJECTIONRLD, RS, Approved before 19828869cabd3fbd…
2020-11-12 02:37 UTC2020-11N006823-001AQUASOL AEQ 50,000 UNITS BASE/MLINJECTABLE / INJECTIONRLD, RS, Approved before 1982c0c555d07b60…
2019-12-14 00:12 UTC2019-12N006823-001AQUASOL AEQ 50,000 UNITS BASE/MLINJECTABLE / INJECTIONRLD, RS, Approved before 19823f01610625f2…
2019-09-15 20:21 UTC2019-09N006823-001AQUASOL AEQ 50,000 UNITS BASE/MLINJECTABLE / INJECTIONRLD, RS, Approved before 1982b00525d2431f…
2019-07-19 19:46 UTC2019-07N006823-001AQUASOL AEQ 50,000 UNITS BASE/MLINJECTABLE / INJECTIONRLD, RS, Approved before 1982ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N006823-001AQUASOL AEQ 50,000 UNITS BASE/MLINJECTABLE / INJECTIONRLD, RS, Approved before 19826a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N006823-001AQUASOL AEQ 50,000 UNITS BASE/MLINJECTABLE / INJECTIONRLD, RS, Approved before 19821c564ffb4f44…
2023-12-20 04:57 UTC2023-12N006823-001AQUASOL AEQ 50,000 UNITS BASE/MLINJECTABLE / INJECTIONRLD, RS, Approved before 1982ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N006823-001AQUASOL AEQ 50,000 UNITS BASE/MLINJECTABLE / INJECTIONRLD, RS, Approved before 1982a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N006823-001AQUASOL AEQ 50,000 UNITS BASE/MLINJECTABLE / INJECTIONRLD, RS, Approved before 19829b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N006823-001AQUASOL AEQ 50,000 UNITS BASE/MLINJECTABLE / INJECTIONRLD, RS, Approved before 1982a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N006823-001AQUASOL AEQ 50,000 UNITS BASE/MLINJECTABLE / INJECTIONRLD, RS, Approved before 19823f0d92c62455…
2023-05-13 08:27 UTC2023-05N006823-001AQUASOL AEQ 50,000 UNITS BASE/MLINJECTABLE / INJECTIONRLD, RS, Approved before 1982053a50430f4f…
2023-01-26 05:58 UTC2023-01N006823-001AQUASOL AEQ 50,000 UNITS BASE/MLINJECTABLE / INJECTIONRLD, RS, Approved before 19823bdfa0b2c4d7…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
d04dff75-58eb-4656-9956-5e7cc64a3700b1c00853-695a-4859-6c8b-22374a98f46d2021-08-02Warnings, Adverse reactionsExact identifier
spl id: d04dff75-58eb-4656-9956-5e7cc64a3700
spl set id: b1c00853-695a-4859-6c8b-22374a98f46d

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.